In addition, it was recently reported that PVT1 upregulation in response to carboplatin-docetaxel treatment in the 3AO ovarian cancer cell line is a determinant of the induction of p53 and TIMP1 mRNA expression and an associated decrease in cell proliferation [65]. This evidence concerns the gene TP53 and ovarian carcinoma.